🟢 Gossamer Bio is trading 8.6% up today as biotech stocks rally

Gossamer Bio is trading at $11.72, up 8.57%, as biotech-sector strength and a broader risk-on market rebound support the move.

• No fresh company-specific announcement clearly explains the September 17 move; recent coverage centers on the September 10 reverse split and earlier seralutinib filing plans.
• The XBI biotech ETF is up 2.55%.
• Trading remains volatile following the reverse split and recent sharp price swings.